6549.TWO
Price:
$7.99
Market Cap:
$640.17M
TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company also develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis. The company was incorporated in 2011 and is based in Zhubei, Taiwan.
Industry
Biotechnology
IPO Date
2015-10-21
Stock Exchange
TWO
Ticker
6549.TWO
According to TaiwanJ Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -24.97. This represents a change of 16.79% compared to the average of -21.38 of the last 4 quarters.
The mean historical PE Ratio of TaiwanJ Pharmaceuticals Co., Ltd. over the last ten years is -76.22. The current -24.97 PE Ratio has changed 3.18% with respect to the historical average. Over the past ten years (40 quarters), 6549.TWO's PE Ratio was at its highest in in the June 2023 quarter at 38.33. The PE Ratio was at its lowest in in the December 2019 quarter at -77.10.
Average
-76.22
Median
-44.43
Minimum
-183.50
Maximum
-8.57
Discovering the peaks and valleys of TaiwanJ Pharmaceuticals Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.04%
Maximum Annual PE Ratio = -8.57
Minimum Annual Increase = -85.89%
Minimum Annual PE Ratio = -183.50
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -28.09 | -84.69% |
| 2023 | -183.50 | 2.04% |
| 2022 | -8.57 | -85.89% |
| 2021 | -60.77 | 174.18% |
| 2020 | -22.16 | -85.63% |
The current PE Ratio of TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-73.39
5-year avg
-60.62
10-year avg
-76.22
TaiwanJ Pharmaceuticals Co., Ltd.’s PE Ratio is greater than Vectorite Biomedical Inc. (-27.18), greater than Health & Life Co., Ltd. (-37.83), less than BioLASCO Taiwan Co., Ltd. (16.84), less than Original BioMedicals Co., Ltd. (-10.78), less than Eusol Biotech Co.,Ltd. (-22.66), less than Bioray Biotech Co., Ltd (20.56), less than SynCore Biotechnology Co.,Ltd (-17.35), less than Pharmigene, Inc. (-6.95), greater than Sofiva Genomics Co.,Ltd. (-84.23), less than Andros Pharmaceuticals Co.,Ltd (-12.62),
| Company | PE Ratio | Market cap |
|---|---|---|
| -27.18 | $630.31M | |
| -37.83 | $530.97M | |
| 16.84 | $815.74M | |
| -10.78 | $955.47M | |
| -22.66 | $856.25M | |
| 20.56 | $627.21M | |
| -17.35 | $909.02M | |
| -6.95 | $524.90M | |
| -84.23 | $644.56M | |
| -12.62 | $1.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiwanJ Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TaiwanJ Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TaiwanJ Pharmaceuticals Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
What is the highest PE Ratio for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
What is the 3-year average PE Ratio for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
What is the 5-year average PE Ratio for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)?
How does the current PE Ratio for TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) compare to its historical average?